X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7596) 7596
Book Review (909) 909
Publication (213) 213
Newsletter (133) 133
Book Chapter (24) 24
Conference Proceeding (23) 23
Dissertation (10) 10
Magazine Article (7) 7
Newspaper Article (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6116) 6116
humans (5823) 5823
ifosfamide (3744) 3744
oncology (3727) 3727
female (3675) 3675
male (3510) 3510
antineoplastic combined chemotherapy protocols - therapeutic use (3239) 3239
ifosfamide - administration & dosage (3079) 3079
adult (3034) 3034
middle aged (2754) 2754
chemotherapy (2360) 2360
aged (1943) 1943
cancer (1435) 1435
treatment outcome (1376) 1376
adolescent (1372) 1372
etoposide - administration & dosage (1353) 1353
cisplatin - administration & dosage (1334) 1334
cisplatin (1212) 1212
ifosfamide - adverse effects (1173) 1173
antineoplastic combined chemotherapy protocols - adverse effects (1170) 1170
combined modality therapy (1076) 1076
doxorubicin - administration & dosage (1060) 1060
ifosfamide - therapeutic use (1034) 1034
child (933) 933
etoposide (910) 910
cyclophosphamide (823) 823
prognosis (806) 806
lung neoplasms - drug therapy (789) 789
antineoplastic combined chemotherapy protocols - administration & dosage (739) 739
survival rate (705) 705
doxorubicin (703) 703
hematology (683) 683
disease-free survival (678) 678
drug administration schedule (672) 672
pharmacology & pharmacy (669) 669
therapy (654) 654
animals (640) 640
retrospective studies (629) 629
sarcoma (627) 627
neoplasm staging (626) 626
carboplatin - administration & dosage (625) 625
child, preschool (622) 622
sarcoma - drug therapy (615) 615
survival analysis (601) 601
cyclophosphamide - administration & dosage (583) 583
vincristine - administration & dosage (581) 581
carboplatin (544) 544
salvage therapy (511) 511
children (508) 508
tumors (508) 508
survival (503) 503
care and treatment (492) 492
follow-up studies (469) 469
remission induction (469) 469
chemotherapy, adjuvant (468) 468
pediatrics (463) 463
surgery (462) 462
abridged index medicus (457) 457
young adult (449) 449
dose-response relationship, drug (448) 448
paclitaxel (441) 441
trial (441) 441
phase-ii (440) 440
mesna (417) 417
antineoplastic agents - therapeutic use (414) 414
radiotherapy (410) 410
phase-ii trial (403) 403
bone neoplasms - drug therapy (400) 400
carcinoma, non-small-cell lung - drug therapy (395) 395
methotrexate - administration & dosage (393) 393
medicine & public health (383) 383
mesna - administration & dosage (381) 381
paclitaxel - administration & dosage (364) 364
research (357) 357
carcinoma (354) 354
toxicity (350) 350
cisplatin - adverse effects (342) 342
infant (341) 341
prospective studies (334) 334
time factors (333) 333
antineoplastic agents, alkylating - administration & dosage (321) 321
neoplasms - drug therapy (319) 319
antineoplastic agents, alkylating - therapeutic use (315) 315
high-dose chemotherapy (315) 315
risk factors (314) 314
gemcitabine (311) 311
combination chemotherapy (307) 307
neoplasm recurrence, local - drug therapy (307) 307
obstetrics & gynecology (307) 307
soft tissue neoplasms - drug therapy (307) 307
aged, 80 and over (303) 303
etoposide - adverse effects (303) 303
transplantation (302) 302
metastasis (299) 299
infusions, intravenous (294) 294
antineoplastic agents, alkylating - adverse effects (289) 289
cyclophosphamide - analogs & derivatives (287) 287
antineoplastic agents (285) 285
testicular neoplasms - drug therapy (282) 282
pharmacokinetics (279) 279
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7039) 7039
Japanese (200) 200
German (187) 187
French (152) 152
Chinese (50) 50
Spanish (42) 42
Polish (29) 29
Italian (20) 20
Korean (12) 12
Russian (12) 12
Portuguese (7) 7
Turkish (7) 7
Czech (5) 5
Hungarian (4) 4
Bulgarian (2) 2
Dutch (2) 2
Hebrew (2) 2
Lithuanian (2) 2
Catalan (1) 1
Danish (1) 1
Finnish (1) 1
Norwegian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurophysiologie Clinique / Clinical Neurophysiology, ISSN 0987-7053, 09/2018, Volume 48, Issue 4, p. 232
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.neucli.2018.06.032... 
Ifosfamide
Journal Article
Archives de Pédiatrie, ISSN 0929-693X, 05/2015, Volume 22, Issue 5, pp. 252 - 253
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 12/2017, Volume 38, p. A178
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.revmed.2017.10.146 Le... 
Lupus | Ifosfamide
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2003, Volume 348, Issue 8, pp. 694 - 701
Ewing's sarcoma, a highly malignant tumor of children, adolescents, and young adults, often responds to local excision plus a now-standard four-drug regimen of... 
YOUNG-ADULTS | NO BENEFIT | MEDICINE, GENERAL & INTERNAL | CYCLOPHOSPHAMIDE | PEDIATRIC ONCOLOGY | VINCRISTINE | DOXORUBICIN | EXPERIENCE | COMBINATION | CHILDHOOD | CHILDREN | Bone Neoplasms - mortality | Sarcoma - secondary | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Neuroectodermal Tumors, Primitive - drug therapy | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Sarcoma, Ewing - mortality | Bone Neoplasms - pathology | Treatment Failure | Sarcoma - mortality | Vincristine - administration & dosage | Adult | Female | Bone Neoplasms - drug therapy | Child | Doxorubicin - administration & dosage | Ifosfamide - therapeutic use | Etoposide - adverse effects | Neuroectodermal Tumors, Primitive - mortality | Drug Administration Schedule | Ifosfamide - adverse effects | Etoposide - administration & dosage | Etoposide - therapeutic use | Survival Rate | Dactinomycin - administration & dosage | Sarcoma - drug therapy | Disease Progression | Sarcoma, Ewing - drug therapy | Disease-Free Survival | Sarcoma, Ewing - secondary | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Neuroectodermal Tumors, Primitive - secondary | Etoposide | Evaluation | Drug therapy | Ifosfamide | Ewing's sarcoma | Index Medicus | Abridged Index Medicus
Journal Article
Neurophysiologie Clinique, ISSN 0987-7053, 09/2018, Volume 48, Issue 4, pp. 232 - 232
Journal Article
Annals of Oncology, ISSN 0923-7534, 02/2015, Volume 26, Issue 2, pp. 407 - 414
Background: Four international study groups undertook a large study in resectable osteosarcoma, which included two randomised controlled trials, to determine... 
International collaboration | Osteosarcoma | Trial conduct | Randomised controlled trial | SARCOMA-GROUP | YOUNG-ADULTS | PROGNOSTIC-FACTORS | HIGH-DOSE METHOTREXATE | DOXORUBICIN | randomised controlled trial | trial conduct | IFOSFAMIDE | CANCER | international collaboration | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | CLINICAL-TRIALS | QUALITY-OF-LIFE | osteosarcoma | Osteosarcoma - drug therapy | Humans | Polyethylene Glycols - adverse effects | Male | Cisplatin - administration & dosage | Young Adult | Female | Neoadjuvant Therapy | Bone Neoplasms - drug therapy | Child | Doxorubicin - administration & dosage | Etoposide - adverse effects | Ifosfamide - adverse effects | Etoposide - administration & dosage | Combined Modality Therapy | Bone Neoplasms - surgery | Polyethylene Glycols - administration & dosage | Interferon-alpha - administration & dosage | Methotrexate - adverse effects | Ifosfamide - administration & dosage | Osteosarcoma - surgery | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Cisplatin - adverse effects | Quality of Life | Methotrexate - administration & dosage | Interferon-alpha - adverse effects | Research Design | Doxorubicin - adverse effects | Index Medicus | Original | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 02/2012, Volume 23, Issue 2, pp. 173 - 184
Palifosfamide, the DNA-alkylating metabolite of ifosfamide (IFOS), has been synthesized as a stabilized tris or lysine salt and found to have preclinical and... 
ifosfamide/analogs & derivatives | antineoplastic agents | antineoplastic combined chemotherapy regimens | alkylating | CELLS | ifosfamide/analogs and derivatives | ACTIVATION | SOFT-TISSUE SARCOMAS | CYCLOPHOSPHAMIDE | HIGH-DOSE IFOSFAMIDE | ISOPHOSPHORAMIDE MUSTARD | METRONOMIC CHEMOTHERAPY | MESNA | METABOLISM | ONCOLOGY | DNA | PHARMACOLOGY & PHARMACY | Doxorubicin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Injections, Intravenous | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Biological Availability | Male | Antineoplastic Agents - therapeutic use | Lysine - therapeutic use | Antineoplastic Agents - administration & dosage | Dose-Response Relationship, Drug | Taxoids - therapeutic use | Phosphoramide Mustards - pharmacokinetics | Phosphoramide Mustards - therapeutic use | Phosphoramide Mustards - administration & dosage | Female | Antineoplastic Agents - pharmacokinetics | Ifosfamide - pharmacokinetics | Doxorubicin - administration & dosage | Mammary Neoplasms, Experimental - drug therapy | Lysine - analogs & derivatives | Ifosfamide - therapeutic use | Drug Administration Schedule | Administration, Oral | Leukemia, Experimental - drug therapy | Lysine - administration & dosage | Rats | Rats, Sprague-Dawley | Xenograft Model Antitumor Assays | Disease-Free Survival | Taxoids - administration & dosage | Animals | Lysine - pharmacokinetics | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice, Nude | Mice | Ifosfamide - analogs & derivatives | Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2014, Volume 50, Issue 6, pp. 1137 - 1147
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 03/2017, Volume 104, Issue 3, pp. 208 - 212
Context Ifosfamide remains one of the major cytotoxic drugs for sarcoma management. Ifosfamid-related encephalopathy (IRE) is a rare but severe adverse event,... 
Sarcoma | Ifosfamide | Toxicity | Encephalopathy
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 10/2017, Volume 64, Issue 10, pp. e26538 - n/a
BackgroundCisplatin (Cis), carboplatin (Carb), and ifosfamide (Ifos) are common nephrotoxic chemotherapies. Biomarkers of tubular injury may allow for early... 
ifosfamide | acute kidney injury | nephrotoxicity | cisplatin | carboplatin | urine biomarkers | NGAL | SOLID TUMORS | CISPLATIN-INDUCED NEPHROTOXICITY | MOLECULE-1 | GELATINASE-ASSOCIATED LIPOCALIN | KIM-1 | ONCOLOGY | PEDIATRICS | IFOSFAMIDE-INDUCED NEPHROTOXICITY | HEMATOLOGY | SARCOMA PATIENTS | AKI | Acute Kidney Injury - urine | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Biomarkers - urine | Prospective Studies | Interleukin-18 - blood | Acute Kidney Injury - blood | Humans | Ifosfamide - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carboplatin - administration & dosage | Child, Preschool | Male | Cisplatin - administration & dosage | Neoplasms - drug therapy | Carboplatin - adverse effects | Neoplasms - urine | Pilot Projects | Neoplasms - blood | Ifosfamide - administration & dosage | Cisplatin - adverse effects | Female | Acute Kidney Injury - chemically induced | Child | Lipocalin-2 - blood | Hospital patients | Chemotherapy | Interleukins | Kidney diseases | Children | Biological markers | Cancer | Urine | Creatinine | Kidneys | Toxicity | Ifosfamide | Lipocalin | Interleukin | Standard error | Gelatinase | Cisplatin | Interleukin 18 | Infusion | Biomarkers | Carboplatin | Bioindicators | Diagnostic systems | Injuries | Kidney transplantation | Index Medicus
Journal Article